Novocure (NVCR) to Present Three Abstracts on Tumor Treating Fields and Pancreatic Cancer at ESMO
Tweet Send to a Friend
Novocure (NASDAQ: NVCR) announced today that the company will present three abstracts studying Tumor Treating Fields (TTFields) in pancreatic cancer ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE